Global Fund outlines investment case to end HIV/AIDs, tuberculosis, and malaria
This month, the Global Fund released its investment case during the Preparatory Meeting of the Fund’s Fifth Replenishment in Tokyo. The Global Fund seeks to raise US $13 billion for the 2017-2019 funding cycle. The investment case outlines how financial commitments will accelerate progress in fighting HIV/AIDS, tuberculosis, and malaria. In conjunction with the 2030 goals set by WHO’s Global Technical Strategy for malaria, the Global Fund investment case cites the returns on investment presented by RBM’s Action for Investment to defeat Malaria—a return on investment between 28:1 and 40:1 for achieving the 2030 malaria goals. The Global Fund’s pledging conference will be held in mid-2016.